Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00170118
Other study ID # 49-05
Secondary ID
Status Completed
Phase N/A
First received September 13, 2005
Last updated January 27, 2010
Start date June 2005
Est. completion date September 2006

Study information

Verified date January 2010
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The majority of the study consists of standard of care treatment for people with low back pain that has lasted more than three months. Half of the participants in the study will receive physical therapy from physical therapists that have received additional training in an educational technique. In order to determine if there is a difference in patient outcome when the educational technique is used, you will be asked to complete five short surveys before receiving physical therapy (10 minutes total). A sample of the physical therapy sessions using the educational technique will be videotaped. The videotape will be of the physical therapist to prove they did use the educational technique, not of you the participant in the study. You will remain anonymous and will not be used and the tape will not be used for publication or presentation purposes. You will also be asked to complete one survey after participating in physical therapy (2 minutes), and all five short surveys (10 minutes total) six weeks after your last physical therapy session.

You will be put in one of 2 groups by chance (as in the flip of a coin). A computerized selection process will be used to assign participants to the study. You will not know if you are in the study group or the non-study group.


Description:

This is a pilot study to evaluate the impact of MI on self-efficacy and outcomes for chronic low back pain.

Design Prospective randomized, single blind pilot, controlled study. Patients will be referred from E10 and the Spine Center by contacting the study coordinator. The Coordinator will meet with potential participants, determine if they meet the inclusion and exclusion criteria, obtain informed consent, assess self-efficacy using the Stanford Self efficacy instrument, use en bloc randomization for self-efficacy to the experimental and control group. They will then complete the SF-12, a VAS pain scale, and the Roland and Morris Disability questionnaire, a few questions about employment status and 1 question about satisfaction with care.

The experimental group(goal n=20) will be treated by physical therapists that have been trained in motivational interviewing techniques by a PhD and a sample of these sessions will be videotaped for validation purposes. The control group(goal n=20) will receive PT from any PT as per the normal standard of care.

Both the experimental and control group will complete an additional self-efficacy instrument prior to leaving. Six weeks after the patients participate in a motivational interview session they will be mailed a repeat of all of the previously mentioned instruments including the self-efficacy tool. Patients who return the completed instruments will receive forty dollars. If effect size is small, this pilot study will be underpowered, if a clinically significant trend is observed additional funding will be sought and the experimental and control n will be expanded to 64.

Setting Tertiary academic medical center Participants Referrals from a Spine Center, or a large outpatient Physical Medicine and Rehabilitation practice with at least three months of chronic low back pain.

Primary Outcome Measure Self-efficacy for Managing Chronic disease 6-Item scale

Main Outcome Measures Roland and Morris Disability Questionnaire Pain VAS Satisfaction with care question Disability status question SF-12 Exclusion Criteria Medical /legal involvement Active workers compensation Infection or tumor in spine Active systemic disease in the lumbar spine Multiple other musculoskeletal problems that require Treatment Patients receiving more than 2 PT sessions

Inclusion Criteria Three or more months of low back pain Ability to read, write and speak English


Recruitment information / eligibility

Status Completed
Enrollment 6
Est. completion date September 2006
Est. primary completion date September 2006
Accepts healthy volunteers No
Gender Both
Age group 21 Years and older
Eligibility Exclusion Criteria Medical /legal involvement Active workers compensation Infection or tumor in spine Active systemic disease in the lumbar spine Multiple other musculoskeletal problems that require Treatment Patients receiving more than 2 PT sessions

Inclusion Criteria Three or more months of low back pain Ability to read, write and speak English

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind


Related Conditions & MeSH terms


Intervention

Behavioral:
motivational interviewing


Locations

Country Name City State
United States Mayo Clinic Rochester Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary SF - 12
Primary Self-efficacy for Managing Chronic disease 6-Item scale
Primary Roland and Morris Disability Questionnaire
Primary Pain Visual analog scale
Primary Satisfaction with care question
Secondary Disability status question
See also
  Status Clinical Trial Phase
Completed NCT03243084 - Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy N/A
Suspended NCT04735185 - Stem Cells vs. Steroids for Discogenic Back Pain N/A
Completed NCT03162952 - RAND Center of Excellence for the Study of Appropriateness of Care in CAM
Completed NCT03240146 - Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain N/A
Completed NCT05282589 - Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients N/A
Completed NCT03637998 - Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain N/A
Recruiting NCT02289170 - Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100) N/A
Active, not recruiting NCT01944163 - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain N/A
Completed NCT02231554 - Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial N/A
Recruiting NCT02063503 - Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients N/A
Completed NCT01704677 - Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up N/A
Terminated NCT01620775 - MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain N/A
Completed NCT01177254 - Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions N/A
Completed NCT01490905 - A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain Phase 4
Completed NCT01177241 - Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids N/A
Completed NCT01177280 - Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes N/A
Completed NCT00984815 - Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment Phase 3
Completed NCT00763321 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3
Completed NCT00761150 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3
Completed NCT00767806 - A Study for Patient With Chronic Low Back Pain Phase 3